TrademarkDir
RAPIVAB
LIVE

Serial Number

86141883

Owner

Seqirus UK Limited

Attorney

Erica L. Han

First Use Date

Jan 15, 2015

Filing Date

Dec 12, 2013

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

RAPIVAB Trademark

Serial Number: 86141883 • Registration: 4778059

RAPIVAB is a trademark filed by Seqirus UK Limited on December 12, 2013. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Seqirus UK Limited (138 trademarks)

Point, 29 Market Street

Entity Type: 98

BioCryst Pharmaceuticals, Inc. (40 trademarks)

2190 Parkway Lake Drive
Birmingham, AL 35244

Entity Type: 03

Trademark Details

Filing Date

December 12, 2013

Registration Date

July 21, 2015

First Use Anywhere

January 15, 2015

First Use in Commerce

January 15, 2015

Published for Opposition

November 4, 2014

Goods & Services

pharmaceutical antiviral preparation

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
May 14, 2025 NA89
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
May 14, 2025 RNL1
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
May 14, 2025 89AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
May 14, 2025 APRE
TEAS SECTION 8 & 9 RECEIVED
Dec 11, 2024 E89R
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Jul 21, 2024 REM2
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Jun 24, 2022 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Jun 24, 2022 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jun 22, 2022 APRE
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Feb 23, 2022 ASGN
TEAS SECTION 8 & 15 RECEIVED
Jan 19, 2022 E815
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 6, 2021 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 6, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 6, 2021 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 16, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 16, 2021 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 16, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 16, 2021 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Apr 16, 2021 COAR
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jul 21, 2020 REM1
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 10, 2020 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 23, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 23, 2019 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 23, 2017 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 23, 2017 COAR
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 17, 2017 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 17, 2017 COAR
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Dec 28, 2016 ASGN
REGISTERED-PRINCIPAL REGISTER
Jul 21, 2015 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jun 12, 2015 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jun 11, 2015 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Jun 9, 2015 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jun 4, 2015 AITU
USE AMENDMENT FILED
May 7, 2015 IUAF
TEAS STATEMENT OF USE RECEIVED
May 7, 2015 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 30, 2014 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 4, 2014 NPUB
PUBLISHED FOR OPPOSITION
Nov 4, 2014 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 15, 2014 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Sep 30, 2014 PREV
ASSIGNED TO LIE
Sep 25, 2014 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 13, 2014 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 13, 2014 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 12, 2014 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 12, 2014 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 21, 2014 GNRN
NON-FINAL ACTION E-MAILED
Mar 21, 2014 GNRT
NON-FINAL ACTION WRITTEN
Mar 21, 2014 CNRT
ASSIGNED TO EXAMINER
Mar 21, 2014 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 26, 2013 NWOS
NEW APPLICATION ENTERED
Dec 16, 2013 NWAP

Related Trademarks

More from this Owner

VANTAFLU

VANTAFLU

PANAPREP

PANAPREP

PANVALEM

PANVALEM

PREPDEMIC

PREPDEMIC

FLUVANTAGE

FLUVANTAGE

INFLUENZA A (H5) MONOVALENT VACCINE, ADJUVANTED AUDENZ logo

INFLUENZA A (H5) MONOVALENT VACCINE, ADJUVANTED AUDENZ